Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3219114 | 0.82 | USP2 (0.33) | USP2TSHRCA1CA2CA14 | |
| SCHEMBL18212596 | 0.82 | CA1 (0.39) | CA1CA2CA9 | |
| SCHEMBL1772672 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL10551938 | 0.76 | — | — | |
| Hydrogen Sulfide SCHEMBL29214421 | 0.76 | — | — | |
| SCHEMBL29258156 | 0.73 | — | — | |
| SCHEMBL6013328 | 0.73 | — | — | |
| SCHEMBL27766217 | 0.73 | — | — | |
| SCHEMBL6013343 | 0.73 | — | — | |
| SCHEMBL28110226 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119009196-B | Lithium cobalt oxide battery, preparation method thereof and electric equipment | 比亚迪股份有限公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-3771014-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES | TOMIYAMA PURE CHEMICAL INDUSTRIES LTD (JP) | 2025-03-05 | — | — | EP | disclosed |
| US-12155037-B2 | Nonaqueous electrolyte solution for power storage devices | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2024-11-26 | — | — | US | disclosed |
| CN-119009196-A | Lithium cobalt oxide battery, preparation method thereof and electric equipment | 比亚迪股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| US-20210043973-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2021-02-11 | — | — | US | disclosed |
| EP-3771014-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES | Tomiyama Pure Chemical Industries, Limited (JP) | 2021-01-27 | — | — | EP | disclosed |
| CN-111971841-A | Nonaqueous electrolyte for electricity storage device | 富山药品工业株式会社 | 2020-11-20 | — | — | CN | disclosed |
| US-10468729-B2 | Method for producing non-aqueous electrolyte secondary battery | ENVISION AESC JAPAN LTD. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-10270127-B2 | Nonaqueous electrolyte secondary battery | NISSAN MOTOR CO., LTD. (JP) | 2019-04-23 | — | — | US | disclosed |
| US-20180191027-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | ENVISION AESC JAPAN LTD. (JP) | 2018-07-05 | — | — | US | disclosed |
| US-20070154815-A1 | Secondary battery | NEC CORPORATION (JP) | 2007-07-05 | — | — | US | disclosed |
| US-4950768-A | ANTICARCINOGENIC AGENTS | CRONYN MARSHALL W (US) | 1990-08-21 | — | — | US | disclosed |
| EP-0168478-B1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES | CRONYN, Marshall W. (US) | 1989-04-05 | — | — | EP | disclosed |
| EP-0168478-A4 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. | CRONYN MARSHALL W | 1986-11-07 | — | — | EP | disclosed |
| EP-0168478-A1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES. | CRONYN MARSHALL W | 1986-01-22 | — | — | EP | disclosed |
| WO-1985003075-A1 | CANCER CHEMOTHERAPEUTIC CYCLIC AND ACYCLIC DISULFONIC ESTER COMPOUNDS, METHOD OF USE THEREFOR, AND INTERMEDIATES | CRONYN MARSHALL W | 1985-07-18 | — | — | WO | disclosed |
| US-4523015-A | Process and nitroaminopyrimidone intermediates for histamine H2 -antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1985-06-11 | — | — | US | disclosed |
| EP-0004793-B1 | 2-NITRO AMINOPYRIMIDONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND THEIR USE TO PREPARE 2-AMINOPYRIMIDONE DERIVATIVES WHICH HAVE HISTAMINE H2-ANTAGONIST ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1981-12-30 | — | — | EP | disclosed |
| US-4227000-A | Intermediates in the process for making histamine antagonists | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1980-10-07 | — | — | US | disclosed |
| EP-0004793-A2 | 2-nitro aminopyrimidone derivatives, a process for their preparation and their use to prepare 2-aminopyrimidone derivatives which have histamine H2-antagonist activity | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210043973-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR POWER STORAGE DEVICES | AQP1, NCS1, SLC9A1 | USP2 4650/4885TSHR 4237/4885CA1 785/4885 |
| US-12155037-B2 | Nonaqueous electrolyte solution for power storage devices | AQP1, NCS1, SLC9A1 | USP2 4650/4885TSHR 4237/4885CA1 785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.